487 related articles for article (PubMed ID: 32595137)
1. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study.
Cardwell K; Smith SM; Clyne B; McCullagh L; Wallace E; Kirke C; Fahey T; Moriarty F;
BMJ Open; 2020 Jun; 10(6):e035087. PubMed ID: 32595137
[TBL] [Abstract][Full Text] [Related]
2. Supporting prescribing in Irish primary care: protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care.
Cardwell K; Clyne B; Moriarty F; Wallace E; Fahey T; Boland F; McCullagh L; Clarke S; Finnigan K; Daly M; Barry M; Smith SM;
Pilot Feasibility Stud; 2018; 4():122. PubMed ID: 30002869
[TBL] [Abstract][Full Text] [Related]
3. Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial.
Croke A; Moriarty F; Boland F; McCullagh L; Cardwell K; Smith SM; Clyne B
BMJ Open; 2021 Mar; 11(3):e041541. PubMed ID: 33753432
[TBL] [Abstract][Full Text] [Related]
4. Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.
Ó Ciardha D; Blake AM; Creane D; Callaghan MÓ; Darker C
BMJ Open; 2022 May; 12(5):e050261. PubMed ID: 35623753
[TBL] [Abstract][Full Text] [Related]
5. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
[TBL] [Abstract][Full Text] [Related]
6. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
7. The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems.
Kirwan C; Hynes L; Hart N; Mulligan S; Leathem C; McQuillan L; Maxwell M; Carr E; Roche K; Walkin S; McCarthy C; Bradley C; Byrne M; Smith SM; Hughes C; Corry M; Kearney PM; McCarthy G; Cupples M; Gillespie P; Hobbins A; Newell J; Glynn L; Roshan D; Sinnott C; Murphy AW
Pilot Feasibility Stud; 2022 Oct; 8(1):225. PubMed ID: 36195963
[TBL] [Abstract][Full Text] [Related]
8. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study.
Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Turner D; Zermansky A; Wright D;
Trials; 2020 Jan; 21(1):103. PubMed ID: 31964398
[TBL] [Abstract][Full Text] [Related]
9. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
Hasan Ibrahim AS; Barry HE; Hughes CM
Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
[TBL] [Abstract][Full Text] [Related]
11. Pharmacists in general practice: a qualitative process evaluation of the General Practice Pharmacist (GPP) study.
James O; Cardwell K; Moriarty F; Smith SM; Clyne B
Fam Pract; 2020 Oct; 37(5):711-718. PubMed ID: 32377672
[TBL] [Abstract][Full Text] [Related]
12. Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician's prescribing, a non-randomised comparative study.
Sloeserwij VM; Zwart DLM; Hazen ACM; Poldervaart JM; Leendertse AJ; de Bont AA; Bouvy ML; de Wit NJ; de Gier HJ
Int J Clin Pharm; 2020 Oct; 42(5):1293-1303. PubMed ID: 32789761
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review.
Croke A; Cardwell K; Clyne B; Moriarty F; McCullagh L; Smith SM
BMC Prim Care; 2023 Feb; 24(1):41. PubMed ID: 36747132
[TBL] [Abstract][Full Text] [Related]
14. An external pilot cluster randomised controlled trial of a theory-based intervention to improve appropriate polypharmacy in older people in primary care (PolyPrime).
Rankin A; Gorman A; Cole J; Cadogan CA; Barry HE; Agus A; Logan D; McDowell C; Molloy GJ; Ryan C; Leathem C; Maxwell M; Brennan C; Gormley GJ; Ferrett A; McCarthy P; Fahey T; Hughes CM;
Pilot Feasibility Stud; 2022 Sep; 8(1):203. PubMed ID: 36088445
[TBL] [Abstract][Full Text] [Related]
15. Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot).
Muth C; Harder S; Uhlmann L; Rochon J; Fullerton B; Güthlin C; Erler A; Beyer M; van den Akker M; Perera R; Knottnerus A; Valderas JM; Gerlach FM; Haefeli WE
BMJ Open; 2016 Jul; 6(7):e011613. PubMed ID: 27456328
[TBL] [Abstract][Full Text] [Related]
16. Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study.
Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Birt L; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Zermansky A; Wright D;
Trials; 2020 May; 21(1):439. PubMed ID: 32471514
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of integrating clinical pharmacists within general practice to optimise prescribing and health outcomes in primary care patients with polypharmacy: A protocol for a systematic review.
Croke A; James O; Clyne B; Moriarty F; Cardwell K; Smith SM
HRB Open Res; 2019; 2():32. PubMed ID: 32296750
[No Abstract] [Full Text] [Related]
18. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study).
Clyne B; Cooper JA; Hughes CM; Fahey T; Smith SM;
Trials; 2016 Aug; 17(1):386. PubMed ID: 27488272
[TBL] [Abstract][Full Text] [Related]
19. A Delphi study to explore and gain consensus regarding the most important barriers and facilitators affecting physiotherapist and pharmacist non-medical prescribing.
Graham-Clarke E; Rushton A; Marriott J
PLoS One; 2021; 16(2):e0246273. PubMed ID: 33529197
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial.
Neilson AR; Bruhn H; Bond CM; Elliott AM; Smith BH; Hannaford PC; Holland R; Lee AJ; Watson M; Wright D; McNamee P
BMJ Open; 2015 Apr; 5(4):e006874. PubMed ID: 25833666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
